(Q35070936)

6 August 2017

1 reference

title

Use of methotrexate in juvenile idiopathic arthritis (English)

1 reference

juvenile rheumatoid arthritis

6 August 2017

1 reference

1 reference

Ramanan AV

1

1 reference

6 August 2017

Whitworth P

series ordinal

2

1 reference

6 August 2017

Baildam EM

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

Archives of Disease in Childhood

6 August 2017

1 reference

6 August 2017

88

1 reference

6 August 2017

197-200

1 reference

6 August 2017

3

1 reference

Polyarticular juvenile idiopathic arthritis treated with methotrexate complicated by the development of non-Hodgkin's lymphoma

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

A combination of etanercept and methotrexate for the treatment of refractory juvenile idiopathic arthritis: a pilot study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Low dose weekly methotrexate in early pregnancy. A case series and review of the literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Discontinuation of methotrexate treatment in juvenile rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Possible mechanisms of action of methotrexate in patients with rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Clinical teratology counseling and consultation case report: low dose methotrexate exposure in the early weeks of pregnancy

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Antifolates in rheumatoid arthritis: a hypothetical mechanism of action.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Polygammaglutamyl metabolites of methotrexate.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Safety and efficacy of methotrexate therapy for juvenile rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Morbidity associated with long-term methotrexate therapy in juvenile rheumatoid arthritis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Methotrexate-induced congenital malformations

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1719480

Methotrexate in the treatment of children with chronic arthritis--long-term observations of efficacy and safety

27 September 2018

1 reference

12 December 2020

Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate

1 reference

12 December 2020

Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group

1 reference

12 December 2020

Methotrexate in juvenile idiopathic arthritis: answers and questions

1 reference

12 December 2020

Methotrexate therapy in juvenile rheumatoid arthritis: a retrospective study

1 reference

12 December 2020

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in plasma and bone marrow of children receiving low-dose oral methotrexate

1 reference

12 December 2020

Toxicity and serum levels of methotrexate in children with juvenile rheumatoid arthritis

1 reference

12 December 2020

Low-dose methotrexate in systemic onset juvenile chronic arthritis

1 reference

12 December 2020

Evaluation of methotrexate in the treatment of juvenile chronic arthritis according to the subtype

1 reference

12 December 2020

Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis

1 reference

12 December 2020

A comparison of low dose methotrexate bioavailability: oral solution, oral tablet, subcutaneous and intramuscular dosing

1 reference

12 December 2020

The mechanism of action of methotrexate in rheumatoid arthritis: the search continues

1 reference

12 December 2020

Factors associated with response to methotrexate in systemic-onset juvenile chronic arthritis

1 reference

12 December 2020

Evaluation of response to methotrexate by a functional index in juvenile chronic arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ADC.88.3.197

1 reference

6 August 2017

1 reference

6 August 2017

1 reference